Wasif Saif
Position Title
Professor - Clinician Educator
Hematology/Oncology
Office Location
Karmanos Cancer Institute
Hudson-Webber Cancer Research Center - 4262
4100 John R.
Detroit, MI 48201
Mailing Address
Karmanos Cancer Institute
4100 John R.
Mail Code: HW04HO
Detroit, MI 48201
Office Phone
313-576-8706
Office Fax
313-576-8766Education Training
Education
(1999 - 2000) Fellowship, National Cancer Institute (NCI) and National Heart, Lung, and Blood Institute (NHLBI),NIH, Bethesda, MD
(1996 - 1998) Residency, Internal Medicine, University of Connecticut Health Center, Farmington, CT
(1986 - 1993) Bachelor of Medicine & Bachelor of Surgery (MBBS) King Edward Medical University, Lahore, Pakistan
Professional Experience
Faculty Appointments
(3/2024 - Present) Professor, Clinician Educator, Department of Oncology, Wayne State University School of Medicine, Detroit, MI
(10/2022 - 3/2024) Professor of Internal Medicine, University of Central Florida (UCF), FL
(4/2019 - 4/2022) Professor, Center for Health Innovations and Outcome Research, The Feinstein Institute for Medical Research, Manhasset, NY
(1/2019 - 4/2022) Professor, Medical Oncology, Zucker School of Medicine at Hofstra/ Northwell, Hempstead, NY
(7/2012 - 12/2018) Professor of Medicine, Tufts University School of Medicine, Boston, MA
(8/2010 - 6/2012) Professor of Clinical Medicine, Division of Hematology/ Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY
(7/2005 - 7/2010) Associate Professor, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT
(10/2001 - 6/2005) Assistant Professor, Department of Clinical Pharmacology and Toxicology (tenure track), University of Alabama at Birmingham (UAB), Birmingham, AL
(7/2001 - 6/2005) Assistant Professor, Division of Hematology/Oncology, Department of Medicine (tenure track), University of Alabama at Birmingham (UAB), Birmingham, AL
Hospital or Other Professional Appointments
(3/2024 - Present) Leader Phase I MDT, Karmanos Cancer Institute, Detroit, MI
(3/2024 - Present) Director Eisenberg Center for Translational Therapeutics, Karmanos Cancer Institute, Detroit, MI
(3/2024 - Present) Gastrointestinal Oncology MDT Co-Leader & Co-Director, Karmanos Cancer Institute, Detroit, MI
(5/2022 - 12/2023) Attending Physician, ORMC, Orlando, FL
(5/2022 - 12/2023) Deputy Director, Orlando Health Cancer Institute, Orlando, FL
(5/2022 - 12/2023) Chair, Medical Oncology/Hematology. Orlando Health, Orlando, FL
(1/2019 - 4/2022) Staff Physician, Northwell Health, Lake Success, NY
(1/2019 - 12/2021) Deputy Physician-in-Chief & Medical Director, Northwell Health Cancer Institute, Lake Success, NY
(1/2019 - 12/2021) Chair, Hematology-Oncology, ORMC, Orlando, FL
(10/2019 - 4/2022) Associate Member, Cold Spring Harbor Laboratories, NY
(7/2012 - 12/2018) Program Leader, Experimental Therapeutics, Tufts Medical Center, Boston, MA
(7/2012 - 12/2018) Director, GI Oncology Program, Tufts Medical Center, Boston, MA
(7/2012 - 12/2018) Attending Physician, Tufts Medical Center, Boston, MA
(8/2010 - 6/2012) Director, GI Cancers in the Division Hematology/Oncology, Herbert Irving Comprehensive Cancer Center (HICCC), Columbia University College of Physicians and Surgeons, New York, NY
(8/2010 - 6/2012) Medical Director of the Pancreas Center, New York-Presbyterian Hospital, New York, NY
(8/2010 - 6/2012) Senior Member, Prevention, Control & Disparities, Herbert Irving Comprehensive Cancer Center (HICCC), Columbia University, College of Physicians and Surgeons, New York, NY
(8/2010 - 6/2012) Attending Physician, New York-Presbyterian Hospital, New York, NY
(10/2009 - 7/2010) Attending Physician, Smilow Cancer Hospital, New Haven, CT
(7/2005 - 7/2010) Director, GI Cancer Disease Program, Yale Cancer Center, New Haven, CT
(10/2001-6/2005) Associate Scientist, UAB Comprehensive Cancer Center, Birmingham, AL
(1/2000 - 6/2001) Medical Staff Fellow in GI Oncology, Medicine Branch, National Cancer Institute (NCI), National Institutes of Health (NIH) & National Naval Medical Center (NNMC), Bethesda, MD
(1/2000 - 12/2000) Instructor, Uniformed Services University of Health Sciences (USUHS), Bethesda, MD
Major Professional Societies
(2022 - Present) Florida Society of Clinical Oncology (FLASCO)
(2022 - Present) Florida Medical Association
(2016 - Present) NANETS
(2013 - Present) International Society of Gastrointestinal Oncology (ISGIO)
(2013 - Present) GI Clinical Trial Working Group at Hoosier Oncology Group
(2012 - Present) MA Medical Society
(2011 - Present) European Society of Medical Oncology (ESMO)
(2011 - Present) Pancreas Club
(2011 - Present) Pancreatic Cancer Research Team (PCRT)
(2004 - Present) American College of Surgical Oncology (ACOSOG)
(2001 - Present) American Society of Pharmacology and Experimental Therapeutics (ASPET)
(2000 - Present) Southern Association for Oncology (SOA)
(2000 - Present) American Society of Clinical Oncology (ASCO)
(1999 - Present) Southern Medical Association (SMA)
(1993 - Present) Pakistan Medical and Dental Association (PMDC)
Board Certification
American Board of Internal Medicine
(2001 - Present) Medical Oncology (Certified)
Honors and Awards
(2023) PanCan Captain of Florida
(2021) Award by Wah Medical College
(2020) Fellows’ Recognition Shield
(2020) MWH Planetree Caregiver Recognition Award
(2017) APPNA, ANMOLIANS, NUMS Scientific Symposium Recognition Award
(2013) Hero of 2013
(2013) POF Hospital Wah Award
(2012) Giovanni Verrelli Spirit Award
(2009) Yale New Haven Hospital (YNHH) Medical Staff Service Excellence Recognition
(2008) Ehrlich II, 150th Nobel Prize Laureate Award Meeting
(2007) FABB Grant for Pancreatic Cancer Research
Research Interests
Dr. Saif has an extensive background in translational research and developing and managing clinical trials. As the Phase I Clinical Trials MDT leader, he will lead a team of physician co-investigators, non-physician providers, clinical personnel, and Clinical Trials Office staff to oversee Phase I solid tumor investigations. Karmanos’ Phase I team oversees over 70 clinical trials at various stages of the protocol lifecycle. Members of this MDT include medical oncologists specializing in many different cancers, who research, study, and develop therapies, bringing them from lab to bedside.